✦ LIBER ✦

Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins

✍ Scribed by van Beers, Miranda M. C.; Bardor, Muriel

Book ID: 118753387
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 424 KB
Volume: 7
Category: Article
ISSN: 1860-6768
DOI: 10.1002/biot.201200065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Managing uncertainty: A perspective on r

Managing uncertainty: A perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins.

✍ Amy S. Rosenberg; Daniela Verthelyi; Barry W. Cherney 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Design of Experiments-Based Monitoring o

Design of Experiments-Based Monitoring of Critical Quality Attributes for the Spray-Drying Process of Insulin by NIR Spectroscopy

✍ Morten Jonas Maltesen, Marco van de Weert, Holger Grohganz 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 411 KB

Selective destruction of abnormal protei

Selective destruction of abnormal proteins by ubiquitin-mediated protein quality control degradation

✍ Fredrickson, Eric K.; Gardner, Richard G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 545 KB

Quality attributes of recombinant therap

Quality attributes of recombinant therapeutic proteins: An assessment of impact on safety and efficacy as part of a quality by design development approach

✍ Alex Eon-Duval; Hervé Broly; Ralf Gleixner 📂 Article 📅 2012 🏛 American Institute of Chemical Engineers 🌐 English ⚖ 329 KB

Quality Control of Polyvalent Pneumococc

Quality Control of Polyvalent Pneumococcal Polysaccharide-Protein Conjugate Vaccine by Nephelometry

✍ Chi-Jen Lee 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Rescue of sarcoglycan mutations by inhib

Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications

✍ Tayebeh Soheili; Evelyne Gicquel; Jérôme Poupiot; Luu N'Guyen; Florence Le Roy; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Sarcoglycanopathies (SGP) are a group of autosomal recessive muscle disorders caused by primary mutations in one of the four sarcoglycan genes. The sarcoglycans (α-, β-, γ-, and δ-sarcoglycan) form a tetrameric complex at the muscle membrane that is part of the dystrophin-glycoprotein complex and pl